Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Rheumatologists’ beliefs about medication barely differ from patients’ medication beliefs

View through CrossRef
Rationale, aims and objectivesStudies suggest that both healthcare providers’ and patients’ beliefs about medication influence medication adherence. This study aims to describe and compare rheumatologists’ and patients’ beliefs about medication. MethodData were collected in a specialized rheumatology clinic in the Netherlands. An adapted version of the Beliefs about Medicines Questionnaire (BMQ) was used to measure beliefs about medication in rheumatologists. (Dichotomized) scores on the BMQ of rheumatologists were compared to RA patients’ scores on the BMQ, using t-tests and two-group tests of proportions with 95% confidence intervals.  ResultsTwenty-seven (96% of the eligible) rheumatologists (mean age 42 years, 63% female) and 580 (71% of the eligible) RA patients (mean age 63 years, 68% female) were included. Generally, beliefs about medication did not differ between rheumatologists and patients. Both groups strongly perceived the need to take prescribed medication, but also had significant concerns about the long-term effects of the medication (63% of rheumatologists and 68% of patients expressed concerns). Some differences in beliefs were also present: Fewer rheumatologists worried about the fact that patients have to take medicines (15% versus 44%, respectively) and about the possibility that patients become too dependent on the medicines (15% versus 30%, respectively). ConclusionsThis study indicates that, generally, rheumatologists’ beliefs about medication barely differ from those of patients. However, in some respects, patients do have stronger concerns about medication than rheumatologists. Future research should focus on the interplay between rheumatologists’ and patients’ beliefs about medication and its impact on medication adherence. 
Title: Rheumatologists’ beliefs about medication barely differ from patients’ medication beliefs
Description:
Rationale, aims and objectivesStudies suggest that both healthcare providers’ and patients’ beliefs about medication influence medication adherence.
This study aims to describe and compare rheumatologists’ and patients’ beliefs about medication.
 MethodData were collected in a specialized rheumatology clinic in the Netherlands.
An adapted version of the Beliefs about Medicines Questionnaire (BMQ) was used to measure beliefs about medication in rheumatologists.
(Dichotomized) scores on the BMQ of rheumatologists were compared to RA patients’ scores on the BMQ, using t-tests and two-group tests of proportions with 95% confidence intervals.
  ResultsTwenty-seven (96% of the eligible) rheumatologists (mean age 42 years, 63% female) and 580 (71% of the eligible) RA patients (mean age 63 years, 68% female) were included.
Generally, beliefs about medication did not differ between rheumatologists and patients.
Both groups strongly perceived the need to take prescribed medication, but also had significant concerns about the long-term effects of the medication (63% of rheumatologists and 68% of patients expressed concerns).
Some differences in beliefs were also present: Fewer rheumatologists worried about the fact that patients have to take medicines (15% versus 44%, respectively) and about the possibility that patients become too dependent on the medicines (15% versus 30%, respectively).
 ConclusionsThis study indicates that, generally, rheumatologists’ beliefs about medication barely differ from those of patients.
However, in some respects, patients do have stronger concerns about medication than rheumatologists.
Future research should focus on the interplay between rheumatologists’ and patients’ beliefs about medication and its impact on medication adherence.
 .

Related Results

Evaluation of Rheumatologists’ Teledermatology Practices and Perspectives
Evaluation of Rheumatologists’ Teledermatology Practices and Perspectives
Objective: In their regular practice, rheumatologists often come across patients with skin and nail abnormalities, so they need dermatology consultations. A new option available to...
NICU Medication Errors: Describing the Cause and Nature of Medication Errors in a NICU in Qatar
NICU Medication Errors: Describing the Cause and Nature of Medication Errors in a NICU in Qatar
IntroductionA medication error can be defined as “any error occurring in the medication use process” and focuses on problems with the delivery of medication to a patient [1]. Medic...
Divergent Conceptualizations and Management Strategies for Neurogenic Thoracic Outlet Syndrome: A Qualitative Multispecialty Study
Divergent Conceptualizations and Management Strategies for Neurogenic Thoracic Outlet Syndrome: A Qualitative Multispecialty Study
Abstract Background Neurogenic thoracic outlet syndrome (nTOS) is the most prevalent subtype of thoracic outlet syndrome and remains one of the most controversial conditions in per...
Polish Rheumatologists and Rheumatoid Arthritis Patients Differ in Their Opinions About Treatment Inefficacy
Polish Rheumatologists and Rheumatoid Arthritis Patients Differ in Their Opinions About Treatment Inefficacy
Objectives: This study aims to detect the differences of opinion between rheumatoid arthritis patients and rheumatologists concerning factors affecting escalation of disease modify...
Abstract 2233: Biobehavioral Factors and Heart Failure Medication Adherence
Abstract 2233: Biobehavioral Factors and Heart Failure Medication Adherence
Background: Medication adherence in heart failure (HF) patients reduces hospitalizations and improves outcomes, yet it is variable. This study evaluated adherence rates...
[RETRACTED] Keanu Reeves CBD Gummies v1
[RETRACTED] Keanu Reeves CBD Gummies v1
[RETRACTED]Keanu Reeves CBD Gummies ==❱❱ Huge Discounts:[HURRY UP ] Absolute Keanu Reeves CBD Gummies (Available)Order Online Only!! ❰❰= https://www.facebook.com/Keanu-Reeves-CBD-G...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Improving Safety in Rheumatology Patients by Closing Pre-screening Laboratory Care Gaps with Rheumatologist-Pharmacist Co-management
Improving Safety in Rheumatology Patients by Closing Pre-screening Laboratory Care Gaps with Rheumatologist-Pharmacist Co-management
Objective: To close laboratory screening care gaps via rheumatology-pharmacy co-management in patients starting disease-modifying antirheumatic drugs. Methods: Laboratory data wer...

Back to Top